BR0111325A - processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco - Google Patents

processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco

Info

Publication number
BR0111325A
BR0111325A BRPI0111325-9A BR0111325A BR0111325A BR 0111325 A BR0111325 A BR 0111325A BR 0111325 A BR0111325 A BR 0111325A BR 0111325 A BR0111325 A BR 0111325A
Authority
BR
Brazil
Prior art keywords
snoring
solution
person
product adapted
controlling
Prior art date
Application number
BRPI0111325-9A
Other languages
English (en)
Inventor
Stanley W Jacob
Original Assignee
Elstan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elstan Corp filed Critical Elstan Corp
Publication of BR0111325A publication Critical patent/BR0111325A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCESSO DE CONTROLAR O RONCO EM UMA PESSOA, E, PRO DUTO ADAPATADO PARA USO NO TRATAMENTO DO RONCO Um porcesso de contrle de ronco é fornecido por instilação oral de uma solução que contém 1-20% de metilssulfonilmetano em peso dissolvido em água de modo a cobrir as membranas da mucosa da orofaringe. Preferencialmente, a solução tem entre 10% - 15% em peso de metilssulfonilmetano. A solução pode ser tamponada e/ou pode ser incluído um flavorizante. O processo prefere que a instilação ocorra tão próximo ao evento do sono quanto possível e devia ser pelo menos dentro de trinta (30) minutos até quinze (15) minutos antes que uma pessoa se retire para dormir.A solução pode ser introduzida por spray ou em gotas e é descrito um produto que embala a solução em um recipiente adequando.
BRPI0111325-9A 2000-06-02 2001-06-01 processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco BR0111325A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/586,075 US6440391B1 (en) 2000-06-02 2000-06-02 Management of snoring by oral administration of dimethyl sulfone
PCT/US2001/017705 WO2001093853A1 (en) 2000-06-02 2001-06-01 Management of snoring by oral administration of dimethyl sulfone

Publications (1)

Publication Number Publication Date
BR0111325A true BR0111325A (pt) 2007-05-29

Family

ID=24344202

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0111325-9A BR0111325A (pt) 2000-06-02 2001-06-01 processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco

Country Status (11)

Country Link
US (1) US6440391B1 (pt)
EP (1) EP1294368A4 (pt)
JP (1) JP2003535130A (pt)
CN (1) CN1436073A (pt)
AU (1) AU2001266644A1 (pt)
BR (1) BR0111325A (pt)
CA (1) CA2408633C (pt)
HK (1) HK1054504A1 (pt)
MX (1) MXPA02011832A (pt)
WO (1) WO2001093853A1 (pt)
ZA (1) ZA200210179B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
EP1966229B1 (en) 2005-09-12 2015-10-21 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP1937286B1 (en) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
CA2678500A1 (en) * 2007-02-15 2008-08-21 Derma-Young Ltd. Compositions and methods for enhancing transmucosal delivery
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
MX353712B (es) 2009-10-30 2018-01-24 Abela Pharmaceuticals Inc Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
BR112012010272A2 (pt) * 2009-10-30 2019-10-01 Biogenic Innovations Llc métodos de aumento da eficiência de fermentação de um micro-organismo, in vitro para aumento do crescimento de um ou mais micro-organismos probióticos, para aumento do crescimento de um micro-organismo em uma amostra de teste de diagnóstico e de inibição de atividade microbiana ex vivo, e uso de metilsulfonilmetano (msm)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863748A (en) 1979-08-30 1989-09-05 Herschler R J Dietary products and uses comprising methylsulfonylmethane
US4477469A (en) 1979-08-30 1984-10-16 Herschler R J Preparations containing methylsulfonylmethane and methods of use and purification
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
JPH0253728A (ja) * 1988-08-17 1990-02-22 Mieko Nakamura いびき防止剤
JPH0692859A (ja) * 1991-10-15 1994-04-05 Sorubei Seiyaku Kk いびき防止剤
US5569679A (en) 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
CA2286408A1 (en) * 1999-09-15 2001-03-15 Colin Russell The use of msm

Also Published As

Publication number Publication date
CA2408633A1 (en) 2001-12-13
EP1294368A4 (en) 2006-04-12
CN1436073A (zh) 2003-08-13
HK1054504A1 (zh) 2003-12-05
AU2001266644A1 (en) 2001-12-17
CA2408633C (en) 2004-07-20
WO2001093853A1 (en) 2001-12-13
WO2001093853B1 (en) 2002-02-28
EP1294368A1 (en) 2003-03-26
MXPA02011832A (es) 2004-05-17
WO2001093853A8 (en) 2002-06-27
JP2003535130A (ja) 2003-11-25
ZA200210179B (en) 2003-07-08
US6440391B1 (en) 2002-08-27

Similar Documents

Publication Publication Date Title
BR0111325A (pt) processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE345118T1 (de) Pharmakologische behandlung des schnarchens
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR0317033A (pt) Vitreólise farmacológica
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
USRE33465E (en) Method for reducing the duration of the common cold
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
PL309604A1 (en) Pharmaceutical composition for treating nicotin dependence
CA2332038A1 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
DE69210802D1 (de) Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
DE602004018735D1 (de) Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität
DE59202126D1 (de) Verfahren zur Herstellung einer pharmazeutischen Zubereitung mit wenigstens zwei verschiedenen Wirkstoffen und Verwendung einer solchen Zubereitung.
BR9205700A (pt) Aperfeiçoamento em um processo para purificar e preservar fator IX derivado de plasma do sangue humano ou outra fonte, processos para a preparação de uma composição terapêutica, e para estabilizar fator IX, solução aquosa de fator IX parcialmente purificado, composição terapêutica e processo para tratar doença de christmas.
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
WO2000038620A3 (en) A composition useful to treat periodontal disease
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
FR2571257A1 (fr) Composition destinee a l'humidification de la muqueuse rhino-pharyngee
ATE234620T1 (de) Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis
EP1228761A3 (en) Liquid pharmaceutical composition for treating bone diseases
BG106892U (en) Liquid medicamentous form
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
BG106025U (en) Medicamentous form

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/00 (2006.01), A61K 31/045 (2006.01), A61K 3